Blocking α4β2 and α7 nicotinic acetylcholine receptors inhibits the reinstatement of morphine-induced CPP by drug priming in mice

Behavioural Brain Research

Volumn 220, Issue 1, 2011, Pages 100-105

  Feng, Bin ^a   Xing, Jiang hao ^a   Jia, Dong ^b   Liu, Shui bing ^a   Guo, Hong ju ^a   Li, Xiao qiang ^a   He, Xiao sheng ^c   Zhao, Ming gao ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Conditioned place preference; Morphine; Nicotine; Nicotinic acetylcholine receptor; Reinstatement

Indexed keywords

BUNGAROTOXIN RECEPTOR; DIHYDRO BETA ERYTHROIDINE; METHYLLYCACONITINE; MORPHINE; NICOTINE; NICOTINIC RECEPTOR ALPHA4BETA2;

ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; DRUG RECEPTOR BINDING; LOCOMOTION; MALE; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN FUNCTION;

ACONITINE; ANALYSIS OF VARIANCE; ANIMALS; CHOLINERGIC ANTAGONISTS; CONDITIONING, OPERANT; DIHYDRO-BETA-ERYTHROIDINE; DRUG INTERACTIONS; EXTINCTION, PSYCHOLOGICAL; MALE; MICE; MICE, INBRED BALB C; MORPHINE; MOTOR ACTIVITY; NARCOTICS; NICOTINE; NICOTINIC AGONISTS; REACTION TIME; RECEPTORS, NICOTINIC; REINFORCEMENT (PSYCHOLOGY); TIME FACTORS;

EID: 79851516477     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.01.040     Document Type: Article

References (39)

1. Berrendero F., Kieffer B.L., Maldonado R. Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice. J Neurosci 2002, 22:10935-10940.
2. Berrendero F., Mendizabal V., Robledo P., Galeote L., Bilkei-Gorzo A., Zimmer A., et al. Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. J Neurosci 2005, 25:1103-1112.
3. Zarrindast M.R., Samadi P., Haeri-Rohani A., Moazami N., Shafizadeh M. Nicotine potentiation of morphine-induced catalepsy in mice. Pharmacol Biochem Behav 2002, 72:197-202.
4. Fiore M.C. Treating tobacco use and dependence: an introduction to the US Public Health Service Clinical Practice Guideline. Respir Care 2000, 45:1196-1199.
5. Shalev U., Grimm J.W., Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 2002, 54:1-42.
6. Brigham J., Henningfield J.E., Stitzer M.L. Smoking relapse: a review. Int J Addict 1990, 25:1239-1255.
7. Kassel J.D., Stroud L.R., Paronis C.A. Smoking, stress, and negative affect: correlation, causation, and context across stages of smoking. Psychol Bull 2003, 129:270-304.
8. Zarrindast M.R., Barghi-Lashkari S., Shafizadeh M. The possible cross-tolerance between morphine- and nicotine-induced hypothermia in mice. Pharmacol Biochem Behav 2001, 68:283-289.
9. Suh H.W., Song D.K., Choi S.R., Chung K.M., Kim Y.H. Nicotine enhances morphine- and beta-endorphin-induced antinociception at the supraspinal level in the mouse. Neuropeptides 1996, 30:479-484.
10. Motoshima S., Suemaru K., Kawasaki Y., Jin C., Kawasaki H., Gomita Y., et al. Effects of alpha4beta2 and alpha7 nicotinic acetylcholine receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats. Eur J Pharmacol 2005, 519:91-95.
11. Zarrindast M.R., Faraji N., Rostami P., Sahraei H., Ghoshouni H. Cross-tolerance between morphine- and nicotine-induced conditioned place preference in mice. Pharmacol Biochem Behav 2003, 74:363-369.
12. Walters C.L., Cleck J.N., Kuo Y.C., Blendy J.A. Mu-opioid receptor and CREB activation are required for nicotine reward. Neuron 2005, 46:933-943.
13. Yoo J.H., Lee S.Y., Loh H.H., Ho I.K., Jang C.G. Loss of nicotine-induced behavioral sensitization in micro-opioid receptor knockout mice. Synapse 2004, 51:219-223.
14. Dhatt R.K., Gudehithlu K.P., Wemlinger T.A., Tejwani G.A., Neff N.H., Hadjiconstantinou M. Preproenkephalin mRNA and methionine-enkephalin content are increased in mouse striatum after treatment with nicotine. J Neurochem 1995, 64:1878-1883.
15. Houdi A.A., Dasgupta R., Kindy M.S. Effect of nicotine use and withdrawal on brain preproenkephalin A mRNA. Brain Res 1998, 799:257-263.
16. Isola R., Zhang H., Duchemin A.M., Tejwani G.A., Neff N.H., Hadjiconstantinou M. Met-enkephalin and preproenkephalin mRNA changes in the striatum of the nicotine abstinence mouse. Neurosci Lett 2002, 325:67-71.
17. McBride W.J., Murphy J.M., Ikemoto S. Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies. Behav Brain Res 1999, 101:129-152.
18. Olmstead M.C., Franklin K.B. The development of a conditioned place preference to morphine: effects of microinjections into various CNS sites. Behav Neurosci 1997, 111:1324-1334.
19. Corrigall W.A., Franklin K.B., Coen K.M., Clarke P.B. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl) 1992, 107:285-289.
20. Kelley A.E. Nicotinic receptors: addiction's smoking gun?. Nat Med 2002, 8:447-449.
21. Laviolette S.R., van der Kooy D. The motivational valence of nicotine in the rat ventral tegmental area is switched from rewarding to aversive following blockade of the alpha7-subunit-containing nicotinic acetylcholine receptor. Psychopharmacology (Berl) 2003, 166:306-313.
22. Ward J.M., Cockcroft V.B., Lunt G.G., Smillie F.S., Wonnacott S. Methyllycaconitine: a selective probe for neuronal alpha-bungarotoxin binding sites. FEBS Lett 1990, 270:45-48.
23. Rezayof A., Zatali H., Haeri-Rohani A., Zarrindast M.R. Dorsal hippocampal muscarinic and nicotinic receptors are involved in mediating morphine reward. Behav Brain Res 2006, 166:281-290.
24. Biala G., Staniak N., Budzynska B. Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats. Naunyn Schmiedebergs Arch Pharmacol 2010, 381:361-370.
25. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 1998, 56:613-672.
26. Biala G., Budzynska B., Staniak N. Effects of rimonabant on the reinstatement of nicotine-conditioned place preference by drug priming in rats. Behav Brain Res 2009, 202:260-265.
27. Biala G., Budzynska B. Calcium-dependent mechanisms of the reinstatement of nicotine-conditioned place preference by drug priming in rats. Pharmacol Biochem Behav 2008, 89:116-125.
28. Biala G. Calcium channel antagonists suppress nicotine-induced place preference and locomotor sensitization in rodents. Pol J Pharmacol 2003, 55:327-335.
29. Sahraei H., Fatemi S.M., Pashaei-Rad S., Faghih-Monzavi Z., Salimi S.H., Kamalinegad M. Effects of Papaver rhoeas extract on the acquisition and expression of morphine-induced conditioned place preference in mice. J Ethnopharmacol 2006, 103:420-424.
30. Benturquia N., Le Guen S., Canestrelli C., Lagente V., Apiou G., Roques B.P., et al. Specific blockade of morphine- and cocaine-induced reinforcing effects in conditioned place preference by nitrous oxide in mice. Neuroscience 2007, 149:477-486.
31. Vihavainen T., Piltonen M., Tuominen R.K., Korpi E.R., Ahtee L. Morphine-nicotine interaction in conditioned place preference in mice after chronic nicotine exposure. Eur J Pharmacol 2008, 587:169-174.
32. Moretti M., Mugnaini M., Tessari M., Zoli M., Gaimarri A., Manfredi I., et al. A comparative study of the effects of the intravenous self-administration or subcutaneous minipump infusion of nicotine on the expression of brain neuronal nicotinic receptor subtypes. Mol Pharmacol 2010, 78:287-296.
33. Robbins T.W., Ersche K.D., Everitt B.J. Drug addiction and the memory systems of the brain. Ann N Y Acad Sci 2008, 1141:1-21.
34. Fowler C.D., Arends M.A., Kenny P.J. Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice. Behav Pharmacol 2008, 19:461-484.
35. Elgoyhen A.B., Vetter D.E., Katz E., Rothlin C.V., Heinemann S.F., Boulter J. alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proc Natl Acad Sci USA 2001, 98:3501-3506.
36. Le Novere N., Corringer P.J., Changeux J.P. The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences. J Neurobiol 2002, 53:447-456.
37. Deneris E.S., Connolly J., Rogers S.W., Duvoisin R. Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors. Trends Pharmacol Sci 1991, 12:34-40.
38. Ullian E.M., Sargent P.B. Pronounced cellular diversity and extrasynaptic location of nicotinic acetylcholine receptor subunit immunoreactivities in the chicken pretectum. J Neurosci 1995, 15:7012-7023.
39. Grady S.R., Drenan R.M., Breining S.R., Yohannes D., Wageman C.R., Fedorov N.B., et al. Structural differences determine the relative selectivity of nicotinic compounds for native alpha 4 beta 2*-, alpha 6 beta 2*-, alpha 3 beta 4*- and alpha 7-nicotine acetylcholine receptors. Neuropharmacology 2010, 58:1054-1066.